Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2017 / Aug / Sampling the Spectrum
Neurology Laboratory management Clinical care Screening and monitoring Neurology Endocrinology

Sampling the Spectrum

Blood biomarkers may offer reliable early diagnosis of autism spectrum disorder

By Michael Schubert 08/18/2017 1 min read

Share

Most parents of children with autism will agree that early diagnosis and intervention is best. But autism isn’t always easy to diagnose – the label encompasses a broad spectrum of traits and may present differently in every patient. As a common saying in the community goes, “If you’ve met one person with autism… you’ve met one person with autism.”

Figure 1. Serum levels of a) thyroid-stimulating hormone.
Figure 1. Serum levels of b) interleukin-8 in boys involved in the study. TSH is significantly lower and IL-8 significantly higher in boys on the autism spectrum than in typically developing boys. Adapted from (1).

So how can doctors contend with this diagnostic challenge and ensure patients are treated as early as possible? New research from the University of Texas Southwestern Medical Center has shown that levels of two blood biomarkers, measured together, can accurately diagnose autism in over four-fifths of patients. The study examined a total of 82 boys (43 with autism spectrum disorders; 39 typically developing). In the former group, levels of thyroid stimulating hormone (TSH) were significantly suppressed, whereas levels of interleukin-8 were significantly elevated. Each biomarker predicted autism with approximately 75 percent accuracy, and combining them increased the overall accuracy to 82 percent. The study’s authors suggest pursuing panels of blood proteins as a method of accurately identifying and characterizing autism spectrum disorders. Their next step: to increase their sample size, and to add two further proteins (apolipoprotein E and stem cell factor) to their panel with the hope of improving overall diagnostic accuracy.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. S Singh et al., “Serum thyroid-stimulating hormone and interleukin-8 levels in boys with autism spectrum disorder”, J Neuroinflammation, 14, 113 (2017). PMID: 28577577.

About the Author(s)

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

More Articles by Michael Schubert

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Medicare Pathology Payments in 2021
Laboratory management
Medicare Pathology Payments in 2021

January 26, 2024

1 min read

A national Medicare report extract for pathologists reveals where payments went in the US in 2021

R-Tracker: The First of Its Kind
Laboratory management
R-Tracker: The First of Its Kind

December 29, 2021

1 min read

Milestone is committed to enhancing patient safety with a new disruptive technology

The Pathologist’s 2016 Power List
Laboratory management
The Pathologist’s 2016 Power List

October 18, 2016

1 min read

Let’s celebrate the successes of our field by shining a spotlight on the next generation.

The Times They Are A-Changin’
Laboratory management
The Times They Are A-Changin’

October 21, 2016

1 min read

Or at least I hope they are, but I need your help…

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.